The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...
The U.S. Food and Drug Administration (FDA) discovered undeclared diclofenac and dexamethasone in the product. The FDA previously warned, on November 22, that consumers should not purchase or use ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Earlier this month, GoodRx released a list of the 19 most influential drug and vaccine approvals of 2024, some newly designed to treat certain conditions and other existing medications that were ...
An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a ...
These highlights were written by the reporters and editors who worked on this story. The drug potassium chloride has been on the market for decades, widely prescribed to help the nerves and ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback